The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett's Neoplasia.

MLA

Venkitachalam, Srividya, et al. “The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-Oncogene MYC and Molecular Programs Central to Barrett’s Neoplasia.” Gastroenterology, vol. 163, no. 5, Nov. 2022, pp. 1228–41. EBSCOhost, https://doi.org/10.1053/j.gastro.2022.07.045.

APA

Venkitachalam, S., Babu, D., Ravillah, D., Katabathula, R. M., Joseph, P., Singh, S., Udhayakumar, B., Miao, Y., Martinez-Uribe, O., Hogue, J. A., Kresak, A. M., Dawson, D., LaFramboise, T., Willis, J. E., Chak, A., Garman, K. S., Blum, A. E., Varadan, V., & Guda, K. (2022). The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett’s Neoplasia. Gastroenterology, 163(5), 1228–1241. https://doi.org/10.1053/j.gastro.2022.07.045

Chicago

Venkitachalam, Srividya, Deepak Babu, Durgadevi Ravillah, Ramachandra M Katabathula, Peronne Joseph, Salendra Singh, Bhavatharini Udhayakumar, et al. 2022. “The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-Oncogene MYC and Molecular Programs Central to Barrett’s Neoplasia.” Gastroenterology 163 (5): 1228–41. doi:10.1053/j.gastro.2022.07.045.